OPKO Health Quick Ratio 2010-2024 | OPK
Historical quick ratio values for OPKO Health (OPK) over the last 10 years.
| OPKO Health Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-09-30 | $0.57B | $0.21B | 2.69 |
| 2024-06-30 | $0.30B | $0.22B | 1.36 |
| 2024-03-31 | $0.33B | $0.20B | 1.62 |
| 2023-12-31 | $0.24B | $0.20B | 1.22 |
| 2023-09-30 | $0.29B | $0.20B | 1.44 |
| 2023-06-30 | $0.36B | $0.23B | 1.59 |
| 2023-03-31 | $0.33B | $0.22B | 1.49 |
| 2022-12-31 | $0.32B | $0.21B | 1.50 |
| 2022-09-30 | $0.34B | $0.27B | 1.28 |
| 2022-06-30 | $0.41B | $0.22B | 1.91 |
| 2022-03-31 | $0.66B | $0.31B | 2.12 |
| 2021-12-31 | $0.74B | $0.33B | 2.23 |
| 2021-09-30 | $0.45B | $0.28B | 1.57 |
| 2021-06-30 | $0.41B | $0.30B | 1.36 |
| 2021-03-31 | $0.44B | $0.40B | 1.09 |
| 2020-12-31 | $0.39B | $0.38B | 1.04 |
| 2020-09-30 | $0.32B | $0.34B | 0.94 |
| 2020-06-30 | $0.29B | $0.28B | 1.03 |
| 2020-03-31 | $0.22B | $0.25B | 0.88 |
| 2019-12-31 | $0.27B | $0.25B | 1.09 |
| 2019-09-30 | $0.24B | $0.27B | 0.90 |
| 2019-06-30 | $0.30B | $0.28B | 1.04 |
| 2019-03-31 | $0.39B | $0.40B | 0.99 |
| 2018-12-31 | $0.28B | $0.29B | 0.96 |
| 2018-09-30 | $0.25B | $0.32B | 0.78 |
| 2018-06-30 | $0.28B | $0.31B | 0.90 |
| 2018-03-31 | $0.30B | $0.32B | 0.94 |
| 2017-12-31 | $0.30B | $0.31B | 0.96 |
| 2017-09-30 | $0.38B | $0.26B | 1.48 |
| 2017-06-30 | $0.42B | $0.28B | 1.50 |
| 2017-03-31 | $0.41B | $0.27B | 1.56 |
| 2016-12-31 | $0.44B | $0.26B | 1.66 |
| 2016-09-30 | $0.46B | $0.26B | 1.80 |
| 2016-06-30 | $0.46B | $0.28B | 1.65 |
| 2016-03-31 | $0.41B | $0.27B | 1.55 |
| 2015-12-31 | $0.41B | $0.25B | 1.65 |
| 2015-09-30 | $0.48B | $0.36B | 1.33 |
| 2015-06-30 | $0.26B | $0.18B | 1.43 |
| 2015-03-31 | $0.38B | $0.18B | 2.06 |
| 2014-12-31 | $0.13B | $0.08B | 1.52 |
| 2014-09-30 | $0.15B | $0.08B | 1.91 |
| 2014-06-30 | $0.17B | $0.08B | 2.07 |
| 2014-03-31 | $0.19B | $0.09B | 2.21 |
| 2013-12-31 | $0.23B | $0.09B | 2.45 |
| 2013-09-30 | $0.22B | $0.07B | 3.11 |
| 2013-06-30 | $0.21B | $0.06B | 3.54 |
| 2013-03-31 | $0.22B | $0.06B | 3.69 |
| 2012-12-31 | $0.06B | $0.05B | 1.08 |
| 2012-09-30 | $0.07B | $0.05B | 1.43 |
| 2012-06-30 | $0.08B | $0.03B | 2.37 |
| 2012-03-31 | $0.08B | $0.03B | 2.73 |
| 2011-12-31 | $0.09B | $0.02B | 4.59 |
| 2011-09-30 | $0.11B | $0.02B | 5.29 |
| 2011-06-30 | $0.11B | $0.02B | 5.17 |
| 2011-03-31 | $0.13B | $0.03B | 5.05 |
| 2010-12-31 | $0.04B | $0.03B | 1.48 |
| 2010-09-30 | $0.03B | $0.02B | 1.52 |
| 2010-06-30 | $0.03B | $0.02B | 1.99 |
| 2010-03-31 | $0.05B | $0.03B | 1.76 |
| 2009-12-31 | $0.05B | $0.01B | 4.09 |
| 2009-09-30 | $0.07B | $0.00B | 15.27 |
| 2009-06-30 | $0.05B | $0.01B | 7.11 |
| 2009-03-31 | $0.01B | $0.01B | 0.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.078B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.35 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |